Supplementary Figure 9
Overview of the TIC normalized peak areas of the targeted peptides, analysed in Hela cells treated with 10 ng/mL IFNg or 0.5% BSA for 4 h and 24 h, using PRM measurements. Data are based on 3 experimental replicates.
